Literature DB >> 6805265

Eosinophil diamine oxidase activity in acute inflammation in humans.

J J Herman.   

Abstract

Eosinophil diamine oxidase, histaminase, activity was assayed in acute inflammatory states and correlated to disease activity. Correlation to serum and urine histamine, metabolites of histamine and granulocyte histamine metabolizing enzymes was also studied. Using a radiochromatagraphic assay, diamine oxidase, histaminase, activity was determined in human peripheral blood eosinophils from patients with acute inflammatory states including active asthma, cold-induced urticaria and parasitic infestation; eosinophils from non-active asthmatic patients and normals were used as controls. Eosinophils were purified over a metrizamide discontinuous (16-30%) gradient. Total eosinophils were purified over a metrizamide discontinuous (16-30%) gradient. Total eosinophil histaminase activity was increased two- to three-fold in patients with active disease and returned to lower levels in eosinophils from patients without active disease or with treated disease. Thus, the induction of eosinophil histaminase might be a control mechanism for the inflammation induced by histamine during these acute inflammatory states.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6805265     DOI: 10.1007/BF01965105

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  10 in total

Review 1.  Homeostasis of effector systems which can also be recruited for immunologic reactions.

Authors:  K F Austen
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

2.  Sequential alterations in the human eosinophil content of arylsulfatase B during therapy of Bancroftian filariasis.

Authors:  P F Weller; E A Ottesen; E J Goetzl
Journal:  Clin Immunol Immunopathol       Date:  1981-01

3.  Metabolism of 14C-histamine given intrabronchially to asthmatic patients.

Authors:  G Granerus; J Bergmark; O Löwhagen; G Thiringer
Journal:  Allergy       Date:  1980-01       Impact factor: 13.146

4.  Inactivation of slow reacting substance of anaphylaxis by human eosinophil arylsulfatase.

Authors:  S I Wasserman; E J Goetzl; K F Austen
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

5.  Complement-dependent histaminase release from human granulocytes.

Authors:  J J Herman; I K Rosner; A E Davis; R S Zeiger; M A Arnaout; H R Colten
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

6.  Histamine metabolism. II. Cellular and subcellular localization of the catabolic enzymes, histaminase and histamine methyl transferase, in human leukocytes.

Authors:  R S Zeiger; D L Yurdin; H R Colten
Journal:  J Allergy Clin Immunol       Date:  1976-07       Impact factor: 10.793

7.  Studies on histamine metabolism in intrinsic bronchial asthma.

Authors:  O Löwhagen; G Granerus; H Wetterqvist
Journal:  Allergy       Date:  1979-12       Impact factor: 13.146

8.  Specific modulation of complement-dependent human granulocyte function by imidazole acetic acid.

Authors:  J J Herman; H R Colten
Journal:  J Allergy Clin Immunol       Date:  1980-10       Impact factor: 10.793

9.  In vivo studies of mediator release in cold urticaria and cholinergic urticaria.

Authors:  A P Kaplan; L Gray; R E Shaff; Z Horakova; M A Beaven
Journal:  J Allergy Clin Immunol       Date:  1975-06       Impact factor: 10.793

10.  Measurement of histamine: a quality control study.

Authors:  G J Gleich; W M Hull
Journal:  J Allergy Clin Immunol       Date:  1980-10       Impact factor: 10.793

  10 in total
  2 in total

1.  Activation and release of enzymes and major basic protein from guinea pig eosinophil granulocytes induced by different inflammatory stimuli and other substances. A histochemical, biochemical, and electron microscopic study.

Authors:  H Popper; G Knipping; B M Czarnetzki; R Steiner; G Helleis; H Auer
Journal:  Inflammation       Date:  1989-04       Impact factor: 4.092

2.  Anti-IL5 decreases the number of eosinophils but not the severity of dermatitis in Sharpin-deficient mice.

Authors:  Matthew L Renninger; Rosemarie E Seymour; Laurence O Whiteley; John P Sundberg; Harm Hogenesch
Journal:  Exp Dermatol       Date:  2009-07-23       Impact factor: 3.960

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.